Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Review: The Landscape of Antiviral Therapy for COVID-19 in the Era of Widespread Population Immunity and Omicron-Lineage Viruses

Clinical Infectious Diseases(2023)10.1093/cid/ciad685Source: DataRank Database

Review: The Landscape of Antiviral Therapy for COVID-19 in the Era of Widespread Population Immunity and Omicron-Lineage Viruses is a research paper published in Clinical Infectious Diseases (2023). On theSindex it has a DataRank of 0. It has been cited 17 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access17 citations

Download PDF

Cite:

Linked data & code

nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 2.87)OA: bronzeTopics (36)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (2)

Yijia Li ORCID,Eric A. Meyerowitz ORCID

Live enrichment

PubMed:37949817 PMC:PMC11487108 OpenAlex:https://openalex.org/W4388583175

University of Pittsburgh

Grant: P30 AI036219

Rustbelt CFAR

University Hospitals Cleveland Medical Center

Case Western Reserve University

NIH

FWCI

2.87

Citation Percentile

0.9%

Citation Trend

2024

2025

2026

bronzeLicense: https://academic.oup.com/pages/standard-publication-reuse-rights

journalhttps://academic.oup.com/cid/advance-article-pdf/doi/10.1093/cid/ciad685/53174088/ciad685.pdf

publisherhttps://academic.oup.com/cid/advance-article-pdf/doi/10.1093/cid/ciad685/53174088/ciad685.pdf

publisherhttps://academic.oup.com/cid/advance-article-pdf/doi/10.1093/cid/ciad685/54760052/ciad685.pdf

publisherhttps://academic.oup.com/cid/article-pdf/78/4/908/59836087/ciad685.pdf

journalhttps://doi.org/10.1093/cid/ciad685

Fields of Study

SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesLong-Term Effects of COVID-19HumansCOVID-19SARS-CoV-2Immunity, HerdCOVID-19 SerotherapyAntiviral AgentsRitonavir

MeSH Terms

COVID-19SARS-CoV-2COVID-19 SerotherapyAntiviral AgentsHumansRitonavirImmunity, Herd

Keywords

MedicinePopulationPandemicImmunologyClinical trialDiseaseCoronavirusImmunityAntiviral drugIntensive care medicineCoronavirus disease 2019 (COVID-19)VirusInternal medicineInfectious disease (medical specialty)Immune systemAntiviralsReboundCovid-19Sars-cov-2

Sustainable Development Goals

SDG 0: Good health and well-being

Review: The Landscape of Antiviral Therapy for COVID-19 in the Era of Widespread Population Immunity and Omicron-Lineage Viruses

FAIR Checklist

Authors (2)

Funding (5 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)